knowledge -WSS

knowledge

author：entertainment 2025-10-01 14:17:27 - browse：965

Sorrento Therapeutics — ARIANA DREHSLER/AFP via Getty Images

SAN DIEGO — U.S. legislation that seeks to restrict American biotechs from working with certain Chinese firms and suppliers is for now just that — a proposal, not a law. But the looming bill’s impact was clearly visible at this year’s meeting of the industry’s largest trade group.

A number of biotech companies in attendance at the meeting of the Biotechnology Innovation Organization told STAT they’re actively looking to strike deals with U.S.-based drug manufacturers rather than companies named in the legislation, even though doing so will be more costly. An executive at a U.S.-based contract development and manufacturing organization, or CDMO, who spoke on condition of anonymity, said that “month to month, new business has gone through the roof.”

Meanwhile, some Chinese suppliers not named in the bill are paradoxically drawing increased interest from biotechs — while hearing from some customers worried those manufacturers could be blacklisted in the future.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： STAT wants to know your pick for a great summer read or listen

Wikipedia

WSS

Clinical trials must include more disabled people

FDA approves Moderna’s RSV vaccine, its second licensed product

ASCO Daily Recap: CAR

Baltimore teen accused of firing into crowd during block party mass shooting

Majority of Americans think Trump's Ga. election interference case is serious: POLL

As Maui death toll rises, number of missing remains unclear

Wikipedia

knowledge

This article is exclusive to STAT+ subscribers

Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+.

hotspot

DIEP, the 'gold standard' of breast reconstruction, is under threat

Liz Cheney makes 1st public comment since Trump's election interference indictments

Medical leaders decry Supreme Court decision on affirmative action

As Maui death toll rises, number of missing remains unclear

Psychedelics group wrestles with new pharma identity

Liz Cheney makes 1st public comment since Trump's election interference indictments

Duchenne breakthrough therapy leaves behind pioneering families

Medicare Advantage's lean provider networks lead CMS complaints

BioMarin wins approval for gene therapy to treat hemophilia A

UnitedHealth CEO's Medicaid comments send insurer stocks diving

leisure time

Lung cancer is America's deadliest cancer. Yet so few get screened

Living with Hashimoto's and celiac disease, and med school, too

Senators tussle over abortion against the backdrop of a presidential campaign

Sutter Health’s antitrust win overturned by appeals court

UnitedHealth CEO's Medicaid comments send insurer stocks diving

A new initiative will help leaders fight the next pandemic

entertainment

Wikipedia

knowledge

hotspot